Cargando…

ASO Visual Abstract: Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic

Detalles Bibliográficos
Autores principales:	Williams, Austin D., Chang, Cecilia, Sigurdson, Elin R., Wang, Chihsiung, Aggon, Allison A., Hill, Maureen V., Porpiglia, Andrea, Bleicher, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	ASO Visual Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547306/ http://dx.doi.org/10.1245/s10434-021-10973-4

Ejemplares similares

Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

ASO Visual Abstract: Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

ASO Author Reflections: Neoadjuvant Endocrine Therapy: A Pill in Time Saves Nine
por: Williams, Austin D., et al.
Publicado: (2022)

ASO Visual Abstract: An Analysis of COVID-19 on Surgical Delays in Breast Cancer Patients in NYC Public Hospitals—A Multicenter Study
por: Escobar, Natalie, et al.
Publicado: (2022)

ASO Visual Abstract: Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19
por: Sokas, Claire, et al.
Publicado: (2021)

ASO Visual Abstract: The Breast Cancer Patient Experience of Telemedicine During COVID-19
por: Cadili, Lina, et al.
Publicado: (2022)

ASO Visual Abstract: The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care
por: Johnson, Bryan A., et al.
Publicado: (2021)

ASO Visual Abstract: COVID-19 is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States
por: Davis, Catherine H., et al.
Publicado: (2022)

ASO Visual Abstract: Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management
por: Tonneson, Jennifer E., et al.
Publicado: (2022)

ASO Visual Abstract: Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center
por: Paro, Alessandro, et al.
Publicado: (2022)

ASO Visual Abstract: Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database
por: Nogueira, Leticia M., et al.
Publicado: (2023)

ASO Visual Abstract: Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer
por: Fromer, Marc W., et al.
Publicado: (2021)

ASO Visual Abstract: Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital
por: Kapp, Kelly A., et al.
Publicado: (2022)

ASO Visual Abstract: The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study
por: Rasic, Gordana, et al.
Publicado: (2023)

ASO Visual Abstract: Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed-Methods Study
por: Ludwigson, Abigail, et al.
Publicado: (2022)

ASO Visual Abstract: The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer Centre
por: Doyle, Joseph P., et al.
Publicado: (2023)

ASO Visual Abstract: Breast Cancer Screening, Diagnosis, and Surgery During the Pre- and Peri-pandemic—Experience of Patients in a Statewide Health Information Exchange
por: Milgrom, Zheng Z., et al.
Publicado: (2023)

ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection
por: Kothari, Anai N., et al.
Publicado: (2021)

ASO Visual Abstract: Oncological Surgery during the COVID-19 pandemic—Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection
por: Lopes, André, et al.
Publicado: (2022)

ASO Visual Abstract: Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer—Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries
por: Wilke, Lee G., et al.
Publicado: (2021)

ASO Author Reflections: Right Sizing Axillary Surgery in Patients treated with Neoadjuvant Endocrine Therapy
por: Hieken, Tina J., et al.
Publicado: (2021)

ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA
por: Verdone, Christopher G., et al.
Publicado: (2022)

ASO Author Reflections: Assessing the Impact of Neoadjuvant Therapy: A Real View Perspective
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

ASO Author Reflections: Surgical Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
por: Korrel, Maarten, et al.
Publicado: (2020)

ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy
por: Samiei, Sanaz, et al.
Publicado: (2019)

ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer
por: Relation, Theresa, et al.
Publicado: (2021)

ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma—Does Surgery Tell the Whole Story?
por: Sahakyan, Mushegh A., et al.
Publicado: (2021)

ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients
por: van Loevezijn, Ariane A., et al.
Publicado: (2020)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis
por: Burkbauer, Laura, et al.
Publicado: (2021)

ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
por: Cabalag, Carlos S., et al.
Publicado: (2022)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

ASO Author Reflections: Radiopathomics Strategy of Combing Multi-scale Tumor Information on Pretreatment to Predict the Pathologic Response to Neoadjuvant Therapy
por: Tian, Jie, et al.
Publicado: (2020)

ASO Author Reflections: COVID-19 and Hepatocellular Carcinoma: Vulnerable Patient Populations Will Bear the Brunt of Delayed Treatment
por: Rasic, Gordana, et al.
Publicado: (2023)

ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma
por: Schouten, Thijs J., et al.
Publicado: (2022)

ASO Author Reflections: 30 Years of Esophagectomy
por: Phillips, A. W., et al.
Publicado: (2021)

ASO Author Reflections: Salvage Surgery for Anal Cancer
por: Hagemans, J. A. W.
Publicado: (2018)

ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma
por: Asplund, Johannes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lg5tvua7r78j3ie2ibde9gs6tn